Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism FN1 inhibitors(Fibronectin inhibitors), PAX4 inhibitors(Paired box protein Pax-4 inhibitors), RAPGEF5 inhibitors(Rap guanine nucleotide exchange factor 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure, Diastolic | Discovery | - | 31 May 2022 | |
| Heart Failure, Diastolic | Discovery | - | 31 May 2022 | |
| Other Diseases | Discovery | - | 31 May 2022 | |
| Other Diseases | Discovery | - | 31 May 2022 | |
| Pulmonary Fibrosis | Discovery | - | 31 May 2022 | |
| Pulmonary Fibrosis | Discovery | - | 31 May 2022 |





